RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 92 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $1,455,000 | -34.5% | 68,400 | -8.5% | 0.00% | -50.0% |
Q4 2020 | $2,221,000 | +46.8% | 74,721 | +7.1% | 0.00% | +100.0% |
Q3 2020 | $1,513,000 | -0.2% | 69,800 | +2.6% | 0.00% | 0.0% |
Q2 2020 | $1,516,000 | +52.2% | 68,000 | +3.9% | 0.00% | 0.0% |
Q1 2020 | $996,000 | -3.7% | 65,427 | +45.3% | 0.00% | 0.0% |
Q4 2019 | $1,034,000 | +334.5% | 45,027 | +307.8% | 0.00% | – |
Q3 2019 | $238,000 | – | 11,042 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |